Heat. Heat. Let me ask you something.Have you ever opened your phone to check one message and 30 minutes later you are watching video about how to train a screen. Yeah, me too. We live in the very everything fighting for attention message games reals ass every second being pink screw and you ask yourself why can't I focus anymore the real problem here's the truth you are not lazy you are not weak the problem is the world around you are designed to steal your time so if you feel distracted is not your fault ...

Core Argument - The digital era presents significant challenges to focus due to technological distractions, particularly from social media [1][2] - Focus is a skill that requires learning and practice to combat these distractions [3][4] Strategies for Enhancing Focus - Establish digital boundaries by turning off non-essential notifications, utilizing "do not disturb" mode, and setting time limits for distracting apps [5] - Practice single-tasking instead of multitasking to improve work quality, potentially using techniques like the Pomodoro Technique [6][7] - Prioritize physical and mental well-being, including sufficient sleep (7-8 hours), short walks, and exercises, to enhance concentration [7][8] Conclusion - Technology is a tool that can either aid or hinder focus, depending on how it is used [9] - Increased awareness allows individuals to control technology rather than being controlled by it [9]

Heat. Heat. Hi ladies and gentlemen, my name is Islam.I'm a ninth grader in Yosamas High School. And today I'm going to talk about how we can stay focused and get motivated on digital era. First let's understand why we need to stay focused in our highly technological digital era because even we don't realize that digital devices distract us a lot.They make our work less productive and affect mental health. Then what can we do for focus getting motivated and become more productive. Let me explain it.When we ...

Trading in AstraZeneca's (AZN 2.26%) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly liked that idea, as they bid those ADSes up by more than 2% that trading session. With that rise, it did better than the S&P 500 (^GSPC -0.11%), which closed the day marginally (0.1%) lower.Bye-bye Britain?That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to ...

Core Insights - Entergy has successfully completed the sale of its natural gas distribution business to Delta Utilities, allowing the company to focus on its growing electric utility operations [1][3] - The transaction includes approximately 3,700 miles of natural gas pipelines and 2,200 miles of service lines, serving around 204,000 homes and businesses in Baton Rouge and New Orleans [2] - The sale received all necessary regulatory approvals, indicating a smooth transition process for gas customers [3] Company Focus - The sale enables Entergy to sharpen its focus on electric operations and invest in a more resilient energy future [3] - Entergy Louisiana and Entergy New Orleans provide electric service to over 1.1 million and 209,000 customers respectively, highlighting the company's significant presence in the region [5] - Entergy is committed to investing in cleaner energy generation, including modern natural gas, nuclear, and renewable energy sources [5]

Core Insights - EUROAPI has signed a share purchase agreement for the sale of 100% of EUROAPI UK Ltd, which operates the Haverhill manufacturing site, to Particle Dynamics [1][2] - The divestment is part of EUROAPI's strategy to optimize its industrial footprint and advance its FOCUS-27 transformation plan, enhancing efficiency and focus on its strategic network [2] - The Haverhill site generated approximately 35 million euros in net sales in 2024, with nearly 80% attributed to Sanofi [2] Company Overview - EUROAPI is a leading player in active pharmaceutical ingredients, offering around 200 products and developing innovative molecules through its Contract Development and Manufacturing Organization (CDMO) activities [3] - The company operates six manufacturing sites in Europe and supplies customers in over 80 countries, emphasizing high-quality API manufacturing [4] - EUROAPI is listed on Euronext Paris under the ticker EAPI [4]

Core Points - Legacy Education Inc. announced that Integrity College of Health has received initial accreditation from the NLN CNEA for its RN-BS Track (Distance) program, emphasizing its commitment to high-quality nursing education [1][2] - The accreditation signifies that the RN-BS program meets national standards and reflects a culture of academic excellence and continuous improvement [2] - Dr. Michelle Welch highlighted the accreditation as a recognition of the faculty, staff, and students' efforts, and it reinforces the institution's dedication to evidence-based and accessible education [3] Company Overview - Legacy Education is a nationally accredited, for-profit post-secondary education company founded in 2009, focusing on career-oriented education primarily in healthcare [4] - The company offers a variety of programs including nursing, sonography, medical technicians, and business administration, aiming to provide high-quality, accessible, and affordable education [4] - Legacy Education is committed to expanding its educational offerings through organic growth, new program additions, and strategic acquisitions [4]

Learn more about why you can't focus at work and find techniques you can implement today: https://t.co/f7LgNNsvFC https://t.co/bAlKbAQNqB ...

Core Viewpoint - Autonomix Medical, Inc. has received a significant patent that enhances its position in the nerve-focused therapeutics market, supporting its mission to provide minimally invasive treatments for various nerve-related conditions [1][2]. Group 1: Patent and Technology - The newly issued U.S. Patent No. 12,279,889 B2 ('889 patent) relates to advanced systems for evaluating and modifying neurological functions, including tools for accessing small vessels and treating cancerous tumors [1][3]. - The technology includes integrated sensors in microneedles for deep tissue access, multiband optical sensors for tissue viability, and control systems that adjust treatment based on feedback signals [3][4]. - Autonomix's platform utilizes a catheter-based microchip sensing array that can detect neural signals with greater sensitivity than existing technologies, enabling a precision-guided approach to treat chronic pain and other conditions [4][6]. Group 2: Market Opportunity and Clinical Trials - The patent strengthens Autonomix's intellectual property portfolio, which now includes over 80 issued patents, positioning the company in a multi-billion-dollar market opportunity [1][2]. - The company plans to submit an Investigational Device Exemption (IDE) and begin U.S. clinical trials in 2025 for its Sensing and RF Ablation System, targeting pancreatic cancer pain [5][7]. - The technology aims to address a wide range of conditions influenced by sympathetic nerve activity, including hypertension and chronic pain syndromes, with the potential for numerous applications across various medical fields [1][7].

Learn more about why you can't focus at work and find techniques you can implement today: https://t.co/Y8H6Eq57UM https://t.co/9HoPXIxM6a ...